Highlights
- Market Cap
- $30.98B
- Enterprise Value
- $35.30B
- EPS (TTM)
- $2.20
- PE Ratio
- 25.47
- PEG Ratio
- 2.31
- Total Revenue (TTM)
- $11.82B
- Gross Profit (TTM)
- $3.03B
- EBITDA (TTM)
- $2.83B
- Year Range
- $44.12 - $65.94
- Target Price
- $59.67
- ROA (TTM)
- 5.02%
- ROE (TTM)
- 9.18%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Amrize Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
Amrize Ltd
- 1D
- 4.09%
- 1M
- -13.80%
- YTD
- 3.59%
- 6M
- 15.43%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Jun 23, 2025, AMRZ's average daily return is +0.06%, while the average monthly return is +1.17%. At this rate, your investment would double in approximately 5.0 years.
Historically, 50% of months were positive and 50% were negative. The best month was Feb 2026 with a return of +23.5%, while the worst month was Mar 2026 at -13.8%. The longest winning streak lasted 2 consecutive months, and the longest losing streak was 1 months.
On a daily basis, AMRZ closed higher 49% of trading days. The best single day was Feb 18, 2026 with a return of +11.0%, while the worst single day was Aug 7, 2025 at -6.7%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -2.70% | 23.51% | -13.80% | 3.59% | |||||||||
| 2025 | -4.69% | 3.17% | 1.74% | -6.69% | 6.82% | -0.64% | 4.99% | 4.02% |
Benchmark Metrics
Amrize Ltd has an annualized alpha of 0.56%, beta of 1.35, and R² of 0.22 versus S&P 500 Index. Calculated based on daily prices since June 24, 2025.
- This stock tended to rise when S&P 500 Index fell (downside capture of -257.14%), but participation in market rallies was also limited (-22.14%) — a profile typical of counter-cyclical assets.
- R² of 0.22 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 0.56%
- Beta
- 1.35
- R²
- 0.22
- Upside Capture
- -22.14%
- Downside Capture
- -257.14%
Return for Risk
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Amrize Ltd (AMRZ) and compare them to a chosen benchmark (S&P 500 Index).
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the Amrize Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Amrize Ltd was 20.19%, occurring on Mar 20, 2026. The portfolio has not yet recovered.
The current Amrize Ltd drawdown is 14.94%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -20.19% | Feb 25, 2026 | 18 | Mar 20, 2026 | — | — | — |
| -15.59% | Sep 12, 2025 | 21 | Oct 10, 2025 | 43 | Dec 11, 2025 | 64 |
| -11.98% | Jun 25, 2025 | 31 | Aug 7, 2025 | 20 | Sep 5, 2025 | 51 |
| -8.82% | Jan 13, 2026 | 13 | Jan 30, 2026 | 5 | Feb 6, 2026 | 18 |
| -5.22% | Dec 16, 2025 | 2 | Dec 17, 2025 | 15 | Jan 9, 2026 | 17 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Amrize Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Amrize Ltd is priced in the market compared to other companies in the Building Materials industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for AMRZ, comparing it with other companies in the Building Materials industry. Currently, AMRZ has a P/E ratio of 25.5. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for AMRZ compared to other companies in the Building Materials industry. AMRZ currently has a PEG ratio of 2.3. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for AMRZ relative to other companies in the Building Materials industry. Currently, AMRZ has a P/S ratio of 2.6. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for AMRZ in comparison with other companies in the Building Materials industry. Currently, AMRZ has a P/B value of 2.3. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |